Professor Monica Busse-Morris - Porth Ymchwil - Ffurfwedd Safonol Converis

Ewch i'r Pennawd Ewch i'r Dudalen Lywio Ewch i'r Cynnwys Ewch i'r Troednodyn

Professor Monica Busse-Morris

Prosiectau fel Prif Ymchwiliwr

null

null

1 o 6

null

null

Achieving impact through translation of novel findings of motion perception deficits in Huntington’s disease to therapeutic interventions (01.10.2020 - 30.06.2022)
A definitive multi-centre randomised controlled trial and economic evaluation of a community-based rehabilitation package following hip fracture: Fracture in the elderly multidisciplinary rehabilitation - Phase III (FEMuR III) (01.08.2018 - 31.01.2022)
A multi-site, prospective, longitudinal, cohort study measuring cerebrospinal fluid-mutant Huntington protein in patients with Huntington's disease (01.03.2019 - 28.02.2021)
A randomised controlled feasibility study of TRAK musculoskeletal digital self-management physiotherapy intervention for individuals with musculoskeletal pain
(01.01.2022 - 31.03.2024)
A self-management intervention to support physical activity for people with rare neurological conditions (PARC) (01.09.2018 - 31.10.2019)

Prosiectau fel Cyd-Ymchwiliwr

null

null

1 o 7

null

null

Accessible software to accelerate non-commercial trials for rapid patient impact (01.04.2022 - 31.01.2023)
A device for delivering stem cell therapies to the human brain (15.05.2017 - 31.03.2018)
A longitudinal investigation of new 'smart speaker' personal assistants to improve independence and wellbeing in social care settings (01.02.2020 - 01.06.2024)
An open-label extension study to evaluate the long-term safety and tolerability of intrathecally administered R07234292 (RG6042) in patients with Huntington's disease (BN40955) (01.10.2019 - 31.03.2023)
An open label extension study to investigate the long term safety, tolerability and efficacy of PF-02545920 in subjects with Huntington's disease who previously completed study A8241021 (01.10.2015 - 31.12.2017)